ERDERA, the new European alliance for the research of rare diseases, is hosting a webinar for interested applicants of the upcoming Joint Transnational Call #JTC2025 on December 17!
This call is aimed at international consortia exploring:
“Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.”
Proposals can focus on the following topics:
- Development of pre-clinical therapies using cell, organoid, or animal models.
- Biomarker identification that correlates with therapeutic efficacy.
- Pre-clinical proof-of-concept studies demonstrating pharmacological activity and safety data.
#JTC2025 will open tomorrow (December 10, 2024).
Key deadlines:
- February 13, 2025: Pre-proposal submission deadline.
- July 9, 2025: Full proposal submission deadline.
Funding decisions are expected by December 2025.
Visit ERDERA’s website for more information on the call and to register for the webinar:
Are you interested in forming an international consortium for #JTC2025? No problem! #ZEUSS can help you find suitable international partners and offers support for all your #HorizonEU-related questions!